|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
Pharma Discovery 2001 | ||||||||||||||||
January 17, 2001 | ||||||||||||||||
Vision in Business, Beau-Rivage Palace, Lausanne - Switzerland 12th - 16th February 2001 Day 1 - In-Silico Biology Day 2 - Morning: Plenary Sessions / Afternoon: Novel Technologies & HTS Day 3 - Morning: Outsourcing & Combichem, Developments in Screening / Afternoon: Target Identicication, Genomics, Proteomics & Combichem, Developments in Screening |
||||||||||||||||
Organized by: | Vision in Business | |||||||||||||||
Invited Speakers: | Dr Thomas Colatsky, VP & Chief Scientific Officer, PHYSIOME SCIENCES Mohammad Asfar, Head of Drug Design, RIBOTARGETS Dennis Church, Senior Scientist, SERONO Dr Han van de Waterbeemd, Manager Drug Metabolism, PFIZER Dr Darwin Asa, Chief Scientific Officer - Drug Discovery, TECAN Torsten Schwede, Bioinformatic Scientist, GLAXO WELLCOME Prof Denis Noble, Chairman of the Scientific Advisory Board, PHYSIOME SCIENTCES & Professor of Cardiovascular Physiology, UNIVERSITY OF OXFORD David Owen, Managing Director, CENES Klaus Lindpaintner, VP & Head, ROCHE GENETICS (Eu) Mike Romanos PhD, Director of Molecular Sciences, GLAXO WELLCOME Sheila Ash, Senior Chemoinformatic Consultant, OXFORD MOLECULAR Laurent Bracco, VP Research & Technology, EXONHIT THERAPUTICS Mark Demesmaeker PhD, Scientific Consultant, SPOTFIRE INC Bill Matthews PhD, President & CEO, DELTAGEN INC Dr Jae Carey, Product Mgr - Business Development, PHARMAGENE Dr Tom Mander, Head of Applied Assay Development, EVOTEC Andrew Pakula, VP of Technology & Business Development, PSYCHIATRIC GENOMICS INC Mike Furness, Director of Pharmacogenomics, INCYTE GENOMICS Nigel Beeley, Vice President & Chief Officer, ARENA PHARMACEUTICAL Michael Lajiness, Senior Chemoinformatic Scientist, PHARMACIA CORPORATION Sally Rose, Director, BIOFOCUS PLC Alan Harvey, MD, DRUG DISCOVERY LTD Richard Henfrey PhD, Application Support Director (Europe), AFFYMETRIX John Riley, Int Project Mgr, GLAXO WELLCOME Domini Gostik, Proteomics Marketing Mgr, MICROMASS Martin Valler, Group Leader Molecular Discovery Dept, GLAXO WELLCOME Fareed Aboul-Ela, Head of Structural Biology Grp, RIBOTARGETS Mike Sutcliffe, Reader, LEICESTER UNIVERSITY Paul Doyle, Director of Chemistry, BIOFOCUS PLC Karl Pavey, Research Fellow, UNIVERSITY OF BRIGHTON |
|||||||||||||||
Deadline for Abstracts: | abstracts not required | |||||||||||||||
Registration: | To register please go to the url shown or alternatively call us on +44 (0)207 2565454 or email address given. | |||||||||||||||
E-mail: | karthi.nava@visioninbusiness.com | |||||||||||||||
Posted by: | Karthi Nava | |||||||||||||||
Host: | mail.visioninbusiness.com | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |